Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 132.67%248.18M | ---- | -536.55%-759.61M | ---- | 109.56%174M | ---- | -192.17%-1.82B | ---- | 343.10%1.97B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -47.27%-96.9M | ---- | -184.98%-65.8M | ---- | -859.60%-23.09M | ---- | 42.40%-2.41M | ---- | 51.36%-4.18M |
| Interest expense - adjustment | ---- | -20.37%1.86M | ---- | -76.12%2.34M | ---- | 110.23%9.79M | ---- | -49.13%-95.67M | ---- | -40.98%-64.15M |
| Dividend (income)- adjustment | ---- | -40.88%-16.8M | ---- | 13.44%-11.93M | ---- | 55.73%-13.78M | ---- | -122.84%-31.12M | ---- | ---13.97M |
| Investment loss (gain) | ---- | -31.70%-49.02M | ---- | 40.23%-37.22M | ---- | ---62.27M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 7,696.15%5.93M | ---- | -102.03%-78K | ---- | 1,050.86%3.85M | ---- | -101.61%-405K | ---- | -18.46%25.1M |
| Impairment and provisions: | ---- | -24.68%58.1M | ---- | 185.29%77.14M | ---- | -163.95%-90.44M | ---- | 935.32%141.43M | ---- | -131.94%-16.93M |
| -Impairmen of inventory (reversal) | ---- | 113.08%5.01M | ---- | -4.75%-38.31M | ---- | -135.50%-36.58M | ---- | 262.49%103.02M | ---- | -318.74%-63.4M |
| -Other impairments and provisions | ---- | -54.01%53.09M | ---- | 314.33%115.45M | ---- | -240.24%-53.86M | ---- | -17.35%38.41M | ---- | 93.40%46.47M |
| Revaluation surplus: | ---- | -114.65%-120.74M | ---- | 5,422.51%824.03M | ---- | -100.95%-15.48M | ---- | 180.54%1.62B | ---- | -433.36%-2.02B |
| -Other fair value changes | ---- | -114.65%-120.74M | ---- | 5,422.51%824.03M | ---- | -100.95%-15.48M | ---- | 180.54%1.62B | ---- | -433.36%-2.02B |
| Asset sale loss (gain): | ---- | 229.46%6.86M | ---- | 115.84%2.08M | ---- | 55.69%-13.14M | ---- | 66.36%-29.65M | ---- | -106.89%-88.12M |
| -Loss (gain) from sale of subsidiary company | ---- | -2,805.88%-988K | ---- | ---34K | ---- | ---- | ---- | ---- | ---- | -2,530.71%-12.66M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 270.87%7.84M | ---- | 1,662.50%2.12M | ---- | --120K | ---- | ---- | ---- | 90.42%-80K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 55.28%-13.26M | ---- | 60.67%-29.65M | ---- | -78.28%-75.38M |
| Depreciation and amortization: | ---- | -0.27%101.16M | ---- | 34.40%101.44M | ---- | 2.91%75.47M | ---- | -9.82%73.34M | ---- | 50.16%81.32M |
| -Amortization of intangible assets | ---- | -1.49%7.8M | ---- | -7.06%7.92M | ---- | -4.71%8.52M | ---- | -5.02%8.94M | ---- | -7.11%9.41M |
| Exchange Loss (gain) | ---- | 19.04%-8.03M | ---- | 81.11%-9.92M | ---- | -206.33%-52.5M | ---- | 675.15%49.38M | ---- | 320.11%6.37M |
| Special items | ---- | -87.26%937K | ---- | 160.73%7.36M | ---- | -187.24%-12.11M | ---- | 970.83%13.88M | ---- | 0.93%-1.59M |
| Operating profit before the change of operating capital | ---- | 1.31%131.54M | ---- | 759.07%129.83M | ---- | 74.31%-19.7M | ---- | 35.35%-76.67M | ---- | -1,182.13%-118.59M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -151.82%-45.5M | ---- | -11.41%87.79M | ---- | 175.13%99.1M | ---- | -187.23%-131.91M | ---- | 587.20%151.22M |
| Accounts receivable (increase)decrease | ---- | -65.23%4.05M | ---- | -75.06%11.65M | ---- | 57.49%46.74M | ---- | -2.38%29.68M | ---- | 93.68%30.4M |
| Accounts payable increase (decrease) | ---- | 2,810.59%59.35M | ---- | 103.79%2.04M | ---- | -352.23%-53.82M | ---- | -42.89%21.34M | ---- | 39.39%37.36M |
| Special items for working capital changes | ---- | 196.41%1.64M | ---- | -106.11%-1.7M | ---- | 200.24%27.8M | ---- | -20,598.51%-27.74M | ---- | ---134K |
| Cash from business operations | ---- | -34.20%151.08M | ---- | 129.35%229.61M | ---- | 154.03%100.12M | 120.71%31.92M | -284.83%-185.31M | -340.30%-154.1M | 347.13%100.26M |
| Other taxs | ---- | 48.63%-28.67M | ---- | -158.30%-55.8M | ---- | 23.63%-21.6M | 19.41%-15.66M | 24.97%-28.29M | 31.99%-19.43M | 73.27%-37.7M |
| Interest received - operating | ---- | -23.33%19.24M | ---- | 8.67%25.09M | ---- | 859.60%23.09M | 425.63%6.03M | -42.40%2.41M | -55.56%1.15M | -51.36%4.18M |
| Special items of business | 480.52%23.27M | ---- | -104.02%-6.11M | ---- | --151.97M | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 480.52%23.27M | -28.79%141.65M | -104.02%-6.11M | 95.77%198.9M | 581.90%151.97M | 148.11%101.6M | 112.93%22.29M | -416.45%-211.19M | -182.65%-172.39M | 160.65%66.74M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 32.95%54.37M | 119.23%104.39M | 40.52%40.89M | -17.03%47.61M | -10.70%29.1M | -21.95%57.39M | 45.32%32.59M | 5.29%73.52M | -52.97%22.43M | -10.26%69.83M |
| Loan receivable (increase) decrease | -87.96%3.3M | -74.58%10.16M | 38.01%27.38M | -3.55%39.97M | 38.27%19.84M | -50.61%41.44M | 105.65%14.35M | 182.76%83.91M | -324.06%-253.8M | 47.34%-101.38M |
| Decrease in deposits (increase) | 209.58%517.59M | 60.94%-483.08M | 40.78%-472.32M | ---1.24B | ---797.57M | ---- | ---- | ---- | ---- | -43.81%37.74M |
| Sale of fixed assets | -69.35%593K | 87.53%10.08M | -64.00%1.94M | --5.38M | --5.38M | ---- | ---- | -98.76%1.21M | -99.42%515K | 1,125.30%97.5M |
| Purchase of fixed assets | -21.31%-31.96M | -20.21%-65.88M | -16.14%-26.35M | 23.17%-54.8M | 44.99%-22.68M | -86.45%-71.33M | -164.98%-41.23M | -992.06%-38.26M | -1,031.71%-15.56M | -16.07%-3.5M |
| Purchase of intangible assets | ---1.34M | -322.33%-2.65M | ---- | -31,250.00%-627K | ---186K | 99.98%-2K | ---- | -2,760.78%-13.13M | -5,858.04%-13.35M | 39.92%-459K |
| Sale of subsidiaries | 50.00%3M | ---- | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 97.89%2.98B | 18.23%3.25B | 22.43%1.51B | -24.40%2.75B | -38.19%1.23B | 33.23%3.64B | -3.48%1.99B | -47.61%2.73B | -30.61%2.06B | -23.49%5.22B |
| Cash on investment | -164.78%-3.55B | -19.82%-2.97B | -9.49%-1.34B | 0.62%-2.48B | -44.07%-1.23B | 2.75%-2.49B | 49.25%-850.78M | 47.46%-2.56B | 12.05%-1.68B | 6.18%-4.88B |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --39M |
| Net cash from investment operations | 88.77%-29.59M | 84.73%-141.1M | 65.46%-263.43M | -178.60%-923.98M | -166.67%-762.57M | 324.72%1.18B | 818.83%1.14B | -41.84%276.79M | -90.57%124.48M | -71.82%475.94M |
| Net cash before financing | 97.65%-6.33M | 100.08%548K | 55.86%-269.54M | -156.77%-725.08M | -152.36%-610.59M | 1,846.85%1.28B | 2,534.18%1.17B | -87.91%65.6M | -103.80%-47.9M | -65.63%542.67M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | -66.74%68.77M | -39.33%64.23M | -35.42%206.78M | -59.84%105.87M | -22.64%320.19M |
| Refund | ---- | ---- | ---- | ---- | ---- | -39.25%-243.78M | -22.46%-197.43M | 58.40%-175.06M | 49.51%-161.21M | 41.81%-420.87M |
| Issuing shares | --2.13M | ---- | ---- | ---- | ---- | ---- | ---- | --953K | --1.03M | ---- |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | 9.84%-6.53M | -4.62%-3.62M | 17.56%-7.24M | 26.93%-3.46M | 38.95%-8.79M |
| Dividends paid - financing | -108.31%-62.24M | -60.54%-112.01M | -3.53%-29.88M | -1.29%-69.77M | ---28.86M | 77.08%-68.88M | ---- | 40.14%-300.58M | -89.40%-300.58M | -110.81%-502.16M |
| Other items of the financing business | ---- | --12.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -68.84%-81.18M | -21.31%-133.21M | 8.66%-48.08M | 64.33%-109.81M | 68.40%-52.64M | 7.98%-307.86M | 56.59%-166.6M | 50.30%-334.57M | -54.83%-383.73M | -107.08%-673.2M |
| Effect of rate | 92.80%-738K | -101.31%-545K | -115.52%-10.26M | -35.90%41.52M | -16.98%66.07M | 309.95%64.77M | 649.70%79.58M | 71.66%-30.85M | 82.18%-14.48M | -356.64%-108.87M |
| Net Cash | 72.45%-87.5M | 84.11%-132.66M | 52.11%-317.62M | -186.13%-834.88M | -166.36%-663.23M | 460.38%969.32M | 331.55%999.47M | -106.07%-268.97M | -142.68%-431.64M | -110.41%-130.53M |
| Begining period cash | -7.55%1.63B | -31.01%1.76B | -31.01%1.76B | 67.86%2.56B | 67.86%2.56B | -16.44%1.52B | -16.44%1.52B | -11.60%1.82B | -11.60%1.82B | 169.09%2.06B |
| Cash at the end | 7.41%1.54B | -7.55%1.63B | -26.73%1.44B | -31.01%1.76B | -24.67%1.96B | 67.86%2.56B | 88.95%2.6B | -16.44%1.52B | -53.98%1.38B | -11.60%1.82B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.